Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-11-15

Clinical Trial Update: Intestinal and Nasal Microbiota of Patients With Idiopathic Parkinson's Disease

View source ↗

Summary

Clinical trial update on the intestinal and nasal microbiota of patients with idiopathic Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Parkinson's Disease | Status: COMPLETED